340 likes | 578 Views
Boots Group PLC. Interim Results 2005/06. 27 th October 2005. Sir Nigel Rudd. Chairman. Richard Baker. Chief Executive. Agenda. Overview Richard Baker Financial Review Jim Smart Operational Review Richard Baker. Performance headlines. Continued sales growth in a tough retail market
E N D
Boots Group PLC Interim Results 2005/06 27th October 2005
Sir Nigel Rudd Chairman
Richard Baker Chief Executive
Agenda • Overview Richard Baker • Financial Review Jim Smart • Operational Review Richard Baker
Performance headlines • Continued sales growth in a tough retail market • BTC sales +1.1% • Continued progress in key health and beauty markets • Dispensing volumes +5% • Beauty sales +7% • Delivered against targets for margin, cost and working capital • Group trading profit £163m, down 9.6% reflecting the cost of continued investment • Interim dividend agreed at 9.1p
The Health & Beauty Expert Building a Better Boots 2 years of progress • Strong retail brand operating in growth markets • Significant progress towards a modern, competitive and efficient business • Prices re-positioned • 40 more stores EoT • Extended opening hours • New tills in all stores • Store friendly supply chain • One third less jobs in head office
Transforming the Group • Proposed sale of BHI enables full focus on core chemist chain • Delivered full proceeds of £1.926bn • Stronger balance sheet • 200p special dividend for shareholders • Proposed merger with Alliance UniChem accelerates our plans • Creates Europe’s leading pharmacy-led healthcare group • Step change in UK pharmacy presence with 2,600 outlets • Pan-European buying scale • Enhances international growth opportunities • Delivers substantial cost savings
Jim Smart Chief Financial Officer
Boots The Chemists 6 months to 30th September 2004 £m 2005 £m Like for Like Sales 2,171 2,196 +1.1% -1.3% • PPRS deflation reduces reported BTC sales growth by 1.3% Gross margin movement -180bp -30bp Operating costs +12% +6% Trading profit 202 164 -18.6%
BTC transaction numbers 2005 6 months to 30th September -2.9% Footfall Counter Transactions growth • Total +0.5% • Like for like stores -1.8% Average Transaction Value £8.83 • Growth +3.1%
Continued progress in Health • Sales up 0.6% to £936m • Dispensing volume +5.1%, in line with the market • Dispensing sales value +0.3% • Price deflation • PPRS reduces sales by 4.7%, annualises in Feb ’06 • Generics reduces sales by 1.2%, annualised in Sept ’05 • New contract neutral in H1 • OTC healthcare sales +1.0% • Good growth in vitamins offset by lower hayfever sales
Continued progress in Beauty • Beauty and Toiletries sales up 3.3% to £923m • Beauty sales up 7.3% • Successful investment in own brands and new beauty halls • Premium brands +9% • No7 +12% • Toiletries sales up 2.9% • Successful investment in own brands and strong promotional support • Suncare +16%, • Skincare and Dental strong • Electrical products down 5.9%
Difficult H1 for Lifestyle • Sales down 2.8% to £337m • Baby sales +5.3% • More space • Extended ranges • Food sales -3.9% • Atkins launch in the comparative • Q2 London disruption • Photo sales -10.2% • Gaining share in declining market • Continued growth in digital
Major changes in Boots Opticians • Sales down 10.5% to £83m • Driving efficiency through integration into BTC • Short term disruption • Difficult market conditions • Affected by slower consumer spending • Market expected to remain tough in H2 • Contact lens deregulation
Disposal of BHI • Proposed sale to Reckitt Benckiser plc for £1.926bn, to be completed during early 2006 • £1.43bn (200p per share) to be returned to shareholders by special dividend • Consolidation of shares to maintain comparability of share price and EPS • EPS enhanced by the disposal • £400m to be retained to strengthen the balance sheet and for future investment • Long-term commitment to manufacturing in Nottingham • No adverse impact on Group costs
Balance Sheet • Financial objectives • Strong investment grade debt rating • Adequate cash and earnings cover to dividend • Position at 30th September 2005 • 713m shares ranking for dividend • Net debt £500m, a decrease of £143m • Position post BHI disposal • Zero year end net debt on balance sheet • Ongoing financing charge still expected • Capitalised operating leases of £1.5bn • Property position post sale & leaseback • Remaining freeholds - 100 prime retail sites plus non retail property • NBV £400m, estimated market value at 31st March 2005 £650m
Richard Baker Chief Executive
Clear priorities for BTC Healthcare First Expert Customer Care Only at Boots Right Stores, Right Places Boots for Value
Healthcare First Healthcare First • Our biggest business • 40% of sales, 50% of profits • 100m scripts p.a. • The biggest category all year round • A strong and growing market • A key focus for investment • Smartscript in all stores • Additional capacity to serve care homes • Dispensing sales volume +5%
A strong and growing market Healthcare First • Demographic trends • Greater life expectancy, people older for longer 135 130 125 120 115 Population 1976 =100 110 105 100 95 90 1976 1986 1996 2006 2016 Total population Over retirement age Forecast Forecast Source: ONS
135 130 125 120 115 Population 1976 =100 110 105 100 95 90 1976 1986 1996 2006 2016 Total population Over retirement age Forecast Forecast Source: ONS A strong and growing market Healthcare First • Demographic trends • Greater life expectancy, people older for longer • Continual advances in treatment • Significant area of investment • A priority for government • Healthcare spending as % of GDP • 1997/98 4.2% • 2006/07 6.5% (Plan) • New contract
Growing our pharmacy business Healthcare First • Improving convenience • 31 new pharmacy contracts • Boots.com • Improving service • PCS • Care homes service • New contract services • Improving efficiency • New pharmacy operating model • Professional time freed up for patients
A changing role… Healthcare First • New pharmacy contract • Funding shift to fees and services • Enhanced services • Incremental funding from new sources • E.g Chlamydia testing • Patient Group Directions • Private dispensing unique to Boots • E.g. Boots Weight Loss Programme • Electronic Transfer of Prescriptions • Significant change…significant opportunity
Building differentiation Only at Boots • Major own brands relaunched • No7, No1 cosmetic brand , +12% in H1 • 17 +13% since relaunch • Soltan 5* is the market leader • New exclusive brands in store • Elle McPherson • Ted Baker
Strong growth in Beauty Only at Boots • Growing and attractive market • selected distribution • high service element • Key area for investment • 28 new premium brands in 20 stores • 10 new beauty halls • new fragrance cabinets in 40 stores • Beauty +7% • Cosmetics +13% • Fragrance +3%
Committed to value for money Boots for Value • Continual focus on fair prices • 700 lines reduced by 11% • 200 new price reductions in Baby • Promotions to inspire impulse purchases • Xmas Mix’n’match 3for2 • Full range of price points • Gifts for all • More Xmas gifts at lower price points • Biggest and most generous loyalty card • Baby club
Clear property priorities Right Stores, Right Places • Continue to add space on edge of town • 7 new Edge of Town stores • New stores +2.4% sales in H1 • Drive large store profit intensity • Reduce cost of unproductive space • Property solutions where possible • eg. Brent Cross • Long term planning • Bring small stores up to standard
Expert customer care Expert Customer Care • New uniforms for all Boots people in store • Professional care and advice • 2,000 pharmacists in training for Medicine Usage Review • 150 Accuracy Checking Technicians • 300 more trained Healthcare Assistants • “Trust” based advertising
Driving efficiency • Delivering against £70m productivity target • Store friendly supply chain • Continued benefit of Head Office reductions • Better in store operations • New till based management information • Further buying gains supporting margin • More Far East sourcing for Xmas • eAuctions for own brand products • Advanced negotiation training
Summary • Two major transactions to transform the business • Health and Beauty focus continues to deliver strong results • Delivery against gross margin, productivity and working capital targets • Good progress against clear priorities to build a better Boots • Commitment, discipline and focus
Boots Group PLC Interim Results 2005/06